Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Protein Networks02:26

Protein Networks

3.7K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AAV transduction of human glioblastoma cell lines induces perturbation in cell proliferation.

Molecular therapy. Oncology·2026
Same author

In Vitro Evaluation of PARP1 Inhibitor Olaparib-Cyanine Dye Conjugate for the Treatment of Glioblastoma.

ChemMedChem·2026
Same author

A contribution to the anatomy of two rare cetacean species: The hourglass dolphin (Cephalorhynchus cruciger) and the spectacled porpoise (Phocoena dioptrica).

Anatomical record (Hoboken, N.J. : 2007)·2025
Same author

Global insights into brain tumor registries: Lessons for countries establishing a national brain tumor registry.

Neuro-oncology advances·2025
Same author

Tooth wear and dental calculus in a group of orca (<i>Orcinus orca</i>) stranded on the New Zealand southern coast.

Journal of the Royal Society of New Zealand·2025
Same author

IRF6 controls Epstein-Barr virus (EBV) lytic reactivation and differentiation in EBV-infected epithelial cells.

PLoS pathogens·2025
Same journal

De Novo Lipid Switch Design for Reactive Oxygen Species-Triggered Liposomal Release.

Bioconjugate chemistry·2026
Same journal

Transport of Engineered Nanoparticles in Solid Tumors: Mechanistic Barriers and Emerging Delivery Strategies.

Bioconjugate chemistry·2026
Same journal

One-Pot Orthogonal Dual Functionalization of mi3 Self-Assembling Protein Nanoparticles via Sortase A and SpyCatcher/SpyTag Ligation.

Bioconjugate chemistry·2026
Same journal

Systematic Investigation of Fatty Acids with Different Carbon-Chain Length as Albumin Binder to Improve Tumor Accumulation of Radioligands.

Bioconjugate chemistry·2026
Same journal

Targeted Delivery of RNA Therapeutics through Ligand Conjugation.

Bioconjugate chemistry·2026
Same journal

Rapid and Efficient Antibody-Drug Conjugate Design Using Mechanistic Bottom-Up Modeling from In Vitro to Human.

Bioconjugate chemistry·2026
See all related articles
  1. Home
  3. Harnessing Targeted Protein Degradation For Developing Brain Cancer Therapy.
  1. Home
  3. Harnessing Targeted Protein Degradation For Developing Brain Cancer Therapy.

Related Experiment Video

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

11.7K

Harnessing Targeted Protein Degradation for Developing Brain Cancer Therapy.

Osaid Muhammad1, Sophie White1,2, Carina Dumo1,2,3

  • 1Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.

Bioconjugate Chemistry
|May 4, 2026

View abstract on PubMed

Summary
This summary is machine-generated.

Protein degradation technologies like PROTACs offer new ways to treat brain cancers by degrading disease-causing proteins. This approach may overcome limitations of traditional small molecule inhibitors for better patient outcomes.

More Related Videos

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.2K
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.5K

Related Experiment Videos

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

11.7K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.2K
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.5K

Area of Science:

  • Oncology
  • Neuroscience
  • Drug Discovery

Background:

  • Brain neoplasms present significant treatment challenges due to tumor heterogeneity and the brain's immune-privileged status.
  • Conventional small molecule inhibitors often show incomplete efficacy because of pathway redundancy and compensatory mechanisms.
  • Induced protein degradation is an emerging therapeutic strategy with a novel mechanism of action.

Purpose of the Study:

  • To review the current landscape of protein degradation technologies for brain cancer therapy.
  • To focus on Proteolysis-Targeting Chimeras (PROTACs), molecular glues, and Lysosome-Targeting Chimeras (LYTACs).
  • To discuss the synthesis, biological evaluation, and translational potential of these degradation modalities.

Main Methods:

  • Literature review of protein degradation technologies.
  • Focus on PROTACs, molecular glues, and LYTACs in the context of brain cancer.
  • Analysis of synthesis, biological evaluation, and translational aspects.

    • Main Results:

    • Protein degradation offers a promising approach to overcome limitations of conventional therapies for brain tumors.
    • PROTACs, molecular glues, and LYTACs are key modalities with potential therapeutic applications.
    • These technologies are advancing towards clinical trials for various cancers, including brain neoplasms.

    Conclusions:

    • Protein degradation technologies represent a significant advancement in the development of novel brain cancer therapies.
    • The field holds promise for overcoming treatment resistance and improving patient outcomes.
    • Breakthroughs in induced protein degradation could transform the therapeutic landscape for brain cancer patients.